[Treatment of digitalis-induced arrhythmia].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001949:Bretylium Compounds / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000009:adverse effects* / Q000627:therapeutic use; D004492:Edetic Acid / Q000627:therapeutic use; D004554:Electric Countershock; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008278:Magnesium Sulfate / Q000627:therapeutic use; D008297:Male; D008722:Methods; D008875:Middle Aged; D010138:Pacemaker, Artificial; D010672:Phenytoin / Q000627:therapeutic use; D011189:Potassium Chloride / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D001949:Bretylium Compounds; D004071:Digitalis Glycosides; D010672:Phenytoin; D011189:Potassium Chloride; D008278:Magnesium Sulfate; D008012:Lidocaine; D004492:Edetic Acid; D011802:Quinidine; D011342:Procainamide